Table 1.
Example instruments and tools available for measurement of quality of life in patients with pain and constipation
General health-related measures |
Medical Outcomes Study 36-Item Short-Form (SF-36) [93] |
Medical Outcomes Study 12-Item Short-Form (SF-12) [94] |
Nottingham Health Profile [95] |
World Health Organization Quality of Life (WHOQOL) pain subscale [96] |
Utility measuresa |
EuroQoL [97] |
Health Utilities Index (HUI) [98] |
Cancer pain-specific tools |
Functional Living Index-Cancer (FLIC) [99] |
Functional Assessment of Cancer Therapy-General (FACT-G) [100] |
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ) [101]b |
Gastrointestinal-specific tools for constipation |
Gastrointestinal Symptom Rating Scale (GSRS) [54] |
Elderly Bowel Symptom Questionnaire (EBSQ) [55] |
Patient Assessment of Constipation Symptoms (PAC-SYM) [56]c |
Specific quality of life for constipation |
Patient Assessment of Constipation Quality of Life (PAC-QoL) [57]d |
Opioid-induced constipation-specific tools |
Bowel Function Index (BFI) [58]e |
aSF-36 may be used as a utility measure
bDeveloped for use in international clinical trials
cA 12-item self-report instrument divided into abdominal, rectal and stool domains designed to assess symptom frequency and severity, and validated for use in patients with opioid-induced constipation
dIncludes four subscales: worries and concerns, physical discomfort, psychosocial discomfort and satisfaction
eThe BFI is owned by Mundipharma Laboratories GmbH, Switzerland (2002); the BFI is the subject of a European Patent Application (Publication No. EP 1,860,988) and corresponding patents and patent applications in other countries